[Hepatopulmonary syndrome and portopulmonary hypertension].
(2017) Revue Médicale Suisse — Vol. 13, n° 572, p. 1464-1469 (2017)
Files
MarcuCRevMedSuisse2017.pdf
Open Access - Adobe PDF
- 1.53 MB
Details
- Authors
- Abstract
- Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are two frequent pulmonary complications of liver disease. Portal hypertension is a key element in the pathogenesis of both disorders, which are however distinct in terms of pathogenesis, diagnosis and treatment. HPS corresponds to an abnormal arterial oxygenation in relation with the development of intrapulmonary vascular dilatations. POPH is a pulmonary arterial hypertension in the setting of portal hypertension and elevated pulmonary vascular resistance. As both diseases are associated with an increased risk of morbidity and mortality, it is important to screen and evaluate the severity of these two disorders particularly in liver transplant candidates.
- Affiliations
Citations
Marcu, C., Schiffer, E., Aubert, J.-D., Vionnet, J., Yerly, P., Deltenre, P., & Marot, A. (2017). [Hepatopulmonary syndrome and portopulmonary hypertension]. Revue Médicale Suisse, 13(572), 1464-1469. https://hdl.handle.net/2078.5/125159 (Original work published 2017)